Angiotensin II Induces Neutrophil Accumulation in Vivo Through Generation and Release of CXC Chemokines
Overview
Authors
Affiliations
Background: Angiotensin II (Ang II) is implicated in the development of cardiac ischemic disorders in which prominent neutrophil accumulation occurs. Ang II can be generated intravascularly by the renin-angiotensin system or extravascularly by mast cell chymase. In this study, we characterized the ability of Ang II to induce neutrophil accumulation.
Methods And Results: Intraperitoneal administration of Ang II (1 nmol/L) induced significant neutrophil recruitment within 4 hours (13.3+/-2.3x10(6) neutrophils per rat versus 0.7+/-0.5x10(6) in control animals), which disappeared by 24 hours. Maximal levels of CXC chemokines were detected 1 hour after Ang II injection (577+/-224 pmol/L cytokine-inducible neutrophil chemoattractant [CINC]/keratinocyte-derived chemokine [KC] versus 5+/-3, and 281+/-120 pmol/L macrophage inflammatory protein [MIP-2] versus 14+/-6). Intravital microscopy within the rat mesenteric microcirculation showed that the short-term (30 to 60 minutes) leukocyte-endothelial cell interactions induced by Ang II were attenuated by an anti-rat CINC/KC antibody and nearly abolished by the CXCR2 antagonist SB-517785-M. In human umbilical vein endothelial cells (HUVECs) or human pulmonary artery media in culture, Ang II induced interleukin (IL)-8 mRNA expression at 1, 4, and 24 hours and the release of IL-8 at 4 hours through interaction with Ang II type 1 receptors. When HUVECs were pretreated with IL-1 for 24 hours to promote IL-8 storage in Weibel-Palade bodies, the Ang II-induced IL-8 release was more rapid and of greater magnitude.
Conclusions: Ang II provokes rapid neutrophil recruitment, mediated through the release of CXC chemokines such as CINC/KC and MIP-2 in rats and IL-8 in humans, and may contribute to the infiltration of neutrophils observed in acute myocardial infarction.
Dysfunction of the renin-angiotensin-aldosterone system in human septic shock.
Schaich C, Leisman D, Goldberg M, Filbin M, Khanna A, Chappell M Peptides. 2024; 176:171201.
PMID: 38555976 PMC: 11060897. DOI: 10.1016/j.peptides.2024.171201.
Khan D, Li X, Hashimoto T, Tanikawa R, Niemela M, Lawton M J Am Heart Assoc. 2024; 13(3):e031811.
PMID: 38258667 PMC: 11056163. DOI: 10.1161/JAHA.123.031811.
Devaux C, Camoin-Jau L Viruses. 2023; 15(5).
PMID: 37243131 PMC: 10222462. DOI: 10.3390/v15051045.
COVID-19, Myocarditis and Pericarditis.
Fairweather D, Beetler D, Di Florio D, Musigk N, Heidecker B, Cooper Jr L Circ Res. 2023; 132(10):1302-1319.
PMID: 37167363 PMC: 10171304. DOI: 10.1161/CIRCRESAHA.123.321878.
Devaux C, Lagier J J Clin Med. 2023; 12(6).
PMID: 36983445 PMC: 10056466. DOI: 10.3390/jcm12062445.